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pared the results with those of TEE. Investigators were blind-
ed to the results of both techniques. Plaques were graded on 
CTA according to their presence (0 = not present; 1 = mild;
2 = severe) and degree of calcification (1a or 2a = noncalci-
fied; 1b or 2b = calcified). Associations with risk factors and 
infarct localization were also assessed.  Results: Only 21 of 64 
patients (32.8%) had aortic plaques identified by TEE, com-
pared to 43 of 64 (67.2%) with CTA (p  ! 0.05). The plaque lo-
calization was as follows (TEE vs. CTA): ascending aorta, 10 
vs. 20 (p  ! 0.05); aortic arch, 10 vs. 40 (p  ! 0.05), and descend-
ing aorta, 20 vs. 34 (p  ! 0.05). Grade 1 plaques were most 
commonly found in the aortic arch (25; 39%), while grade 2 
plaques were most often detected in the aortic arch (15; 
23.4%) and the descending aorta (14; 21.9%). There was no 
significant correlation between plaque location, infarct ter-
ritory or vascular risk profile, except for hypertension (p = 
0.003), which was significantly associated with the presence 
of plaques.  Conclusions: CTA identifies more plaques 
throughout the aortic arch and around the origins of the ma-
jor cerebral arteries in particular compared to TEE. These 
may represent potential embolic sources of acute ischemic 
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 Abstract 
 Background: The etiology of ischemic strokes remains cryp-
togenic in about one third of patients, even after extensive 
workup in specialized centers. Atherosclerotic plaques in the 
aorta can cause thromboembolic events but are often over-
looked. They can elude standard identification by trans-
esophageal echocardiography (TEE), which is invasive or
at best uncomfortable for many patients. CT angiography 
(CTA) can be used as an alternative or in addition to TEE if this 
technique fails to visualize every part of the aorta and in par-
ticular the aortic arch.  Methods: We prospectively studied 
64 patients (47 men, age 60  8 13 years) classified as having 
cryptogenic stroke after standard and full workup [including 
brain MRI and 24-hour electrocardiogram (ECG)] with ECG-
triggered CTA of the aorta in search of plaques and com-
 Received: July 15, 2011 
 Accepted: December 12, 2011 
 Published online: February 15, 2012 
 Dr. A. Chatzikonstantinou  
 Department of Neurology, Universitätsmedizin Mannheim  
 Theodor-Kutzer-Ufer 1–3 
 DE–68167 Mannheim (Germany) 
 Tel. +49 621 383 2885, E-Mail chatziko   @   neuro.ma.uni-heidelberg.de 
 © 2012 S. Karger AG, Basel
1015–9770/12/0334–0322$38.00/0 
 Accessible online at:
www.karger.com/ced 
 CT Angiography of the Aorta in 
Cryptogenic Stroke  
Cerebrovasc Dis 2012;33:322–328 323
stroke. Better plaque detection may have an impact on the 
best available secondary prevention regimen in individual 
patients if proximal embolic sources are suspected. 
 Copyright © 2012 S. Karger AG, Basel 
 Introduction 
 Ischemic stroke is a common disease with different 
etiologies. While in many cases a thorough workup per-
formed in a specialized center leads to identification of 
the cause of ischemia, there is still a significant number 
of strokes, estimated at between one fourth to one third 
of cases, for which a definite stroke subtype cannot be 
identified  [1] . In these cases, strokes are classified as being 
of undetermined or unknown cause and are often re-
ferred to as ‘cryptogenic’. Apart from being frustrating 
for both patients and physicians, this diagnosis renders 
selective secondary stroke prevention impossible if stroke 
patterns on neuroimaging suggest a proximal source of 
embolism affecting both the anterior and the posterior 
circulation or both cerebral hemispheres. Intermittent 
atrial fibrillation would result in anticoagulation if even-
tually identified versus antiplatelet agents in those pa-
tients with severe atherosclerosis of the aorta, as used in 
atherosclerosis of other vessels.
 Although many studies have demonstrated an asso-
ciation between atherosclerotic plaques of the aorta and 
recurrent ischemic strokes  [2–7] , these still remain an un-
derestimated factor in the stroke workup in many cen-
ters, while intensive searches for intermittent atrial fibril-
lation, a patent foramen ovale or large- and small-vessel 
atherosclerosis of the cerebral arteries are regularly per-
formed. Data on aortic plaques and their association with 
cerebrovascular events mainly originate from studies 
with transesophageal echocardiography (TEE), which is 
the most frequently used method to visualize the heart 
and the aorta  [2, 8–11] . Because TEE is fairly invasive, not 
always well tolerated by patients and in many cases un-
able to visualize the aortic arch properly  [12] , other meth-
ods for aortic plaque detection have been evaluated. CT 
angiography (CTA) has been shown to have a high sensi-
tivity and specificity for the detection of atherosclerotic 
aortic plaques in a few small studies involving heteroge-
neous stroke subtypes  [6, 13, 14] . Kaya and Yildiz  [15] re-
cently demonstrated that half of stroke cases (in diverse 
stroke groups) had atherosclerotic plaques in the ascend-
ing aorta or the aortic arch, but there was only a small 
group (n = 39) with cryptogenic stroke.
 In this study, we focused on patients with cryptogenic 
stroke and used CTA to detect arteriosclerotic plaques in 
the aorta as possible sources of embolic stroke and com-
pared the results with those of TEE, which was also per-
formed to search for proximal embolic sources including 
aortic plaques, in order to see which technique better de-
tects aortic plaques. Plaque burden and calcification were 
also analyzed.
 Patients and Methods 
 Patients 
 Sixty-four consecutive patients (47 men, 17 women; mean age 
60  8 13 years) admitted to our Stroke Competence Center for 
acute ischemic stroke were studied.  Table  1 shows the baseline 
characteristics of the population. All patients underwent a thor-
ough stroke workup in accordance with international standards, 
including clinical neurological examination, brain MRI (diffu-
sion-weighted, T1-, T2- and T2 * -weighted imaging, as well as 
time-of-flight angiography), vascular imaging (Doppler/duplex), 
monitoring of blood pressure and electrocardiogram (ECG), both 
for at least 24 h, and TEE. 
 The diagnosis of cryptogenic stroke was made after all of the 
above examinations were completed and no certain cause of 
stroke was found. At this point, the Trial of Org 10172 in Acute 
Stroke Treatment (TOAST) classification  [16] for these patients 
was ‘undetermined origin’, and the atherosclerosis, small vessel 
disease, cardiac source, other cause (ASCO) classification  [17] 
delivered no grade 1 pathology. In these cases, the next step ac-
cording to our stroke workup protocol is to perform a CTA of 
the aorta. All patients were informed about the procedure in de-
tail and gave their written informed consent. Risk factors [arte-
rial hypertension (history/treatment or hypertensive blood 
pressure on admission), hyperlipidemia (history/treatment or 
high fasting cholesterol levels), diabetes (history/treatment or 
high fasting glucose levels and elevated glycated hemoglobin), 
history of previous stroke and history of coronary artery dis-
ease] were analyzed. Infarct localization and ischemic patterns 
were recorded according to the corresponding MRI findings 
(anterior, posterior or both circulations; bilateral infarcts, em-
boligenic infarct distribution).
 Transesophageal Echocardiography 
 The ultrasound system GE Vivid (Vivid i and Vivid 7; GE 
Healthcare, UK) with a 5-MHz transducer was used for TEE ex-
aminations. The examination included a search for right-to-left 
shunt (patent foramen ovale), atrial septal aneurysm and intracar-
dial thrombi. The aorta was examined with respect to aortic 
plaques, defined as irregular thickening of the intima with in-
creased echogenicity. TEE was performed and analyzed by an ex-
perienced investigator. The location of aortic plaques was docu-
mented by dividing the aorta into three parts, i.e. the ascending 
aorta, aortic arch and descending aorta.
 Computed Tomography 
 All examinations were performed on a first-generation 64-
channel dual-source CT system (Somatom Definition; Siemens 
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Medical Solutions, Forchheim, Germany). Retrospectively ECG-
gated CTA was performed with the following scan parameters: de-
tector collimation 0.6 mm, gantry rotation time 330 ms, tube cur-
rent time product 320 mAs and a pitch of 0.2–0.5 adapted to the 
heart rate. Low tube voltage (100 kV), automatic tube current mod-
ulation (CARE Dose 4D) and automatic ECG pulsing were used for 
radiation dose reduction in all patients  [18–20] . For vascular en-
hancement, 120 ml of iomeprol 400 (Iomeron 400; Bracco Imaging 
S.p.A., Milan, Italy) were injected using a power injector (Stellant  
D CT Injection System; Medrad Inc., Warrendale, Pa., USA) with 
an injection rate of 4 ml/s, followed by a saline chaser of 40 ml us-
ing the same flow rate. The craniocaudal scan was started using 
automatic bolus triggering and scanned at 2-second intervals in the 
ascending aorta (trigger level 100 Hounsfield Units) with a delay of 
5 s. The patients were instructed to hold their breath at a mild in-
spiratory position. Transversal images of the entire scan range were 
reconstructed with a slice thickness of 1 mm and increments of 0.8 
mm using a standard B30f soft tissue kernel. The volume CT dose 
index and dose length product were recorded. The effective dose of 
the CTA was estimated from the product of the DLP using a con-
version coefficient of 0.017 mSv/mGy/cm as reported in the Euro-
pean Guidelines  [21] for chest examinations.
 Image Analysis 
 The CTA datasets were evaluated by consensus by two radi-
ologists, a board-certified radiologist with 10 years of experience 
in CT imaging and a third-year resident. The thoracic aorta was 
divided into three segments, namely the ascending aorta, aortic 
arch (beginning with the brachiocephalic artery and ending dis-
tal to the left subclavian artery) and descending aorta. For each 
segment, the presence of atherosclerotic plaques was documented 
and assessed on a 3-point scale [grade 0 = not present; grade 1 = 
mild (rare, small plaques); grade 2 = severe (frequent, large 
plaques)]. The atherosclerotic plaques found to be present were 
classified as noncalcified (grade 1a or 2a) or calcified (grade 1b or 
2b) on a segmental basis. 
 Statistical Analysis 
 The 2-tailed Fisher’s exact test and   2 test were used to compare 
TEE and CTA plaque findings as well as associations with risk fac-
tors and infarct localization. The kappa statistic was additionally 
used to calculate agreement between the two techniques. A p value 
 ! 0.05 was considered to indicate a statistically significant differ-
ence. Statistical analysis was performed using the Statistical Pack-
age for the Social Sciences, version 19.0 (IBM, USA).
 Results 
 Table 1 shows patients’ characteristics, risk factors and 
infarct localization and their associations with plaques 
detected by TEE and CTA. There was no significant cor-
relation between diabetes (11/14; 78.6% with plaques), hy-
perlipidemia (23/30; 76.7% with plaques) and coronary 
heart disease (7/10; 70% with plaques) and the atheroscle-
rotic changes in the aorta. Thirty-seven out of 48 patients 
(77.1%) with hypertension had aortic plaques, which was 
shown to be statistically significant (p = 0.003). All but 
one patient with a history of a previous stroke (10/11; 
90.9%) had plaques detected by CTA, but statistical sig-
nificance was missed by a small margin (p = 0.066).
Table 1. P atients’ characteristics, risk factors and infarct distribution
All patients
(n = 64)
P laque detection by CTA
patients without
p laques 
patients with
plaques
p
Age, years1 60813
Men 47 (73.4%)
Risk factors
Diabetes 14 (21.9%) 3 (21.4%) 11 (78.6%) 0.305
Hypertension 48 (75%) 11 (22.9%) 37 (77.1%) 0.003
Hyperlipidemia 30 (46.9%) 7 (23.3%) 23 (76.7%) 0.129
Coronary heart disease 10 (15.6%) 3 (30%) 7 (70%) 0.837
Previous stroke 11 (17.2%) 1 (9.1%) 10 (90.9%) 0.066
Infarct distribution
Anterior circulation only 36 (56.3%) 14 (38.9%) 22 (61.1%) 0.240
Posterior circulation only 20 (31.3%) 6 (30%) 14 (70%) 0.747
Both circulations 8 (12.5%) 1 (12.5%) 7 (87.5%) 0.191
Bilateral infarcts 16 (25%) 5 (31.2%) 11 (68.8%) 0.878
Emboligenic distribution 31 (48.4%) 8 (25.8%) 23 (74.2%) 0.247
Per centages in columns 3 and 4 refer to the total number in column 2.
1 Mean 8 SD.
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 We were particularly interested in patients with cere-
bral infarctions affecting both the anterior and the pos-
terior circulation or both hemispheres. Indeed, 7 of 8 pa-
tients (87.5%) with infarcts in both circulations and 11
of 16 patients (68.8%) with bihemispheric infarcts had 
plaques detected by CTA. However, these results were not 
statistically significant, probably because of the small 
sample size. The emboligenic distribution of infarcts, 
even if they are located only in one brain region, is (as the 
name suggests) also an indication of an embolic stroke 
source. Twenty-three of 31 patients (74.2%; p = 0.247) 
with such an infarct pattern had plaques on CTA.
 Table  2 summarizes the results of plaque detection 
with TEE and CTA. Overall, atherosclerotic plaques were 
identified in 21 patients (32.8%) by TEE. CTA confirmed 
plaques in all of them plus an additional 22 patients (43; 
67.2%; p  ! 0.001,   2 = 15.26,   = 0.488,   = 0.385). In the 
ascending aorta, plaques were identified in 10 patients 
(15.6%) by TEE and in 20 (31.2%) by CTA (p = 0.004,
  2 = 8.28,   = 0.360,   = 0.326). In the aortic arch, CTA 
detected plaques in 4 times as many patients as TEE [40 
(62.5%) vs. 10 (15.6%); p = 0.008,   2 = 7.11,   = 0.333,   = 
0.200]. Results were similar for the descending aorta; 
plaques were found in 20 patients by means of TEE (31.2%) 
compared to 34 patients with CTA (52.3%; p  ! 0.001,
  2 = 15.88,   = 0.498,   = 0.450). Divergent results were 
shown in only 3 cases (4.7%) with plaques in the ascend-
ing aorta detected by TEE but not by CTA and in 2 cases 
(3.1%) with plaques in the descending aorta. In the aortic 
arch, there were no plaques detected solely by TEE and 
not by CTA. The sensitivity of TEE for detecting aortic 
plaques, when compared to CTA, was 48.8%. The average 
radiation dose ( 8 SD) was 15.23  8 9.72 mSv.
 Table 3 summarizes the grading of plaques in the three 
different parts of the aorta as detected by CTA. Most of 
the plaques were found in the aortic arch (40; 62.5%) and 
the descending part of the aorta (34; 53.1%). In the as-
cending aorta, only 20 patients (31.2%) had detectable 
plaques. Grade 1 plaques were most commonly found in 
the aortic arch (n = 25), while grade 2 plaques were most 
frequently found in the aortic arch (n = 15) and the de-
scending aorta (n = 14).  Figure 1 shows examples of CTA 
plaque detection with different grades of plaques.
 Discussion 
 We found that 67.2% of our patients had atheroscle-
rotic aortic plaques. CTA was able to detect them signifi-
cantly more frequently than TEE, while it also detected 
almost all positive TEE findings. Differences were highly 
significant with regard to the total and each of the three 
aortic segments separately. Tenenbaum et al.  [14] com-
pared dual-slice CT with TEE for detecting aortic plaques 
in 32 patients with recent ischemic (but not otherwise 
specified) stroke and/or systemic emboli and came to the 
conclusion that CT showed high accuracy in detecting 
aortic atheroma, especially in areas not clearly depicted by 
TEE. Hussain et al.  [13] also conducted a similar investi-
gation comparing CT with TEE in a general population of 
32 ischemic stroke patients and concluded that CT is sim-
ilar to TEE in detecting aortic plaques and may even be 
better than TEE in detecting smaller atheromas or defin-
ing their morphology. Thus, our results not only confirm 
Table 2. P laque detection results with TEE and CTA
n % p value
Patients with plaques on TEE 21 32.8
Patients with plaques on CTA 43 67.2 <0.001
Patients with plaques on TEE and CTA 21 32.8
Plaque localization
Ascending aorta
TEE
CTA
10
20
15.6
31.2 0.004
Aortic arch
TEE
CTA
10
40
15.6
62.5 0.008
Descending aorta
TEE
CTA
20
34
31.2
52.3 <0.001
Table 3. L ocalization and grading of aortic plaques in 64 patients 
as detected by CTA
Ascending
aorta
Aortic
arch
Descending
aorta
Overall
No plaques 44 (68.8) 24 (37.5) 30 (46.9) 21 (32.8)
Grade 1a 3 (4.7) 9 (14.1) 9 (14.1) 14 (21.9)
Grade 1b 15 (23.4) 16 (25.0) 10 (15.6) 29 (45.3)
Grade 2a 0 3 (4.7) 6 (9.4) 7 (10.9)
Grade 2b 2 (3.1) 12 (18.8) 8 (12.5) 14 (21.9)
Total patients
with plaques 20 (31.2) 40 (62.5) 34 (53.1) 43 (67.2)
Data are presented as n (%). G rade 1: mild; grade 2: severe; a: 
noncalcified plaques; b: calcified plaques.
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the accuracy of CTA reported in previous smaller series 
but also support the hypothesis that CTA is capable of de-
tecting plaques where TEE fails to do so and in the most 
important patient groups for diagnostic purposes (i.e. 
those with cryptogenic strokes) and therapeutic decisions 
(antiplatelet agents vs. anticoagulation). Kaya and Yildiz 
 [15] examined a group of 195 patients with ischemic stroke 
of various classifications, 39 of whom presented with 
cryptogenic stroke. Their patients with cryptogenic stroke 
showed a lower percentage of plaques than in our study 
(20% in the ascending aorta or in the aortic arch and 59% 
in the descending aorta in contrast to a total of 67.2% in 
our patient group). This could be explained by the differ-
ent definition of cryptogenic stroke; our patients had no 
otherwise detectable possible stroke cause, as opposed to 
the study performed by Kaya and Yildiz  [15] , in which the 
group of cryptogenic stroke patients also included pa-
tients in whom more than one potential cause was found 
(including a cardiac source of embolism).
 In our study, most plaques were found in the aortic 
arch (62.5%), followed by the descending part of the aor-
ta (53.1%). In the aortic arch, CTA detected plaques in 
four times as many patients as TEE (40 vs. 10). In this part 
of the aorta, the disagreement between the two tech-
niques was the strongest (  = 0.200), which can probably 
be explained by the fact that anatomic conditions do not 
always allow complete visualization of the aortic arch 
with TEE. It is well known that the distal part of the as-
cending aorta, as well as the proximal/right part of the 
aortic arch, are often poorly visualized in TEE due to the 
juxtaposition of the trachea and the right main bronchus 
between the esophagus and the aorta ( fig. 2 ). While visu-
alization of this area has improved with the aid of newer 
techniques and technology, false-negative results are still 
a b
 Fig. 1. Examples of aortic plaque detection 
by ECG-triggered CTA in sagittal oblique 
maximum-intensity projection of the aor-
ta.  a Multiple calcified plaques can be seen 
in the aortic arch and in the descending 
aorta (grade 2b).  b Some calcified plaques 
can be seen in the descending aorta (grade 
1b). 
 Fig. 2. Approximate illustration of the aortic area in which only 
limited visualization is possible by TEE. Figures refer to numbers 
and percentages of patients with detected plaques. This figure is 
based on a public domain reproduction of a lithograph plate from 
 Gray’s Anatomy . 
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probable  [22, 23] . A high frequency of plaques in the de-
scending aorta was described in previous CTA studies 
 [15] and is confirmed by our data. However, until recent-
ly, plaques in this part of the aorta were not considered 
embolic sources of ischemic stroke  [8, 15] . Recent MRI 
studies using advanced techniques with multidirectional 
velocity mapping have demonstrated that substantial dia-
stolic retrograde flow in the descending aorta is possible; 
therefore, plaques in this region also constitute a poten-
tial embolic source  [24] . 
 Plaque morphology, number and size are also thought 
to play a role in ischemic stroke risk  [6, 9, 25] . High plaque 
complexity was shown to be associated with increased 
stroke risk  [7, 25, 26] . We found that grade 2 plaques (i.e. 
numerous, larger, more complex plaques) were more 
common in the aortic arch and the descending aorta. 
Thus, it can be postulated that plaques located in these 
parts of the aorta are associated with and may even be the 
cause of cryptogenic cerebral ischemia, although this of 
course also depends on several plaque characteristics like 
localization, size, morphology and mobility. Apart from 
that, large plaque burden could also be a good indicator 
of general atherosclerosis.
 As atherosclerotic plaques could act as emboli with 
consecutive stroke, patterns of cerebral infarctions indi-
cating an embolic source, such as infarcts in both the an-
terior and posterior circulations or bilateral infarcts, are 
especially interesting. Kaya and Yildiz  [15] found a high-
er percentage of aortic plaques not in the group of patients 
with cardioembolic infarcts, but rather in the group with 
large artery atherosclerosis (according to the TOAST 
classification). We found a high percentage of patients 
with plaques in the group with acute infarcts in both the 
anterior and posterior circulations (87.5%) and in the 
group with bilateral infarcts (68.8%) using CTA. The 
same applies to the group of patients with emboligenic 
infarct patterns in one hemisphere, 74.2% of whom had 
aortic plaques detected by CTA. In spite of these high per-
centages, statistical significance was not attained. In all 
these cases, TEE could only detect a fraction of the 
plaques, significantly less than CTA. The fact that inter- 
and intraobserver variability was not determined may be 
a limitation of this study. We believe the accuracy of the 
findings to be very high, as the observers were experi-
enced and a well-defined straightforward protocol was 
used; however, the possibility of inter- and intraobserver 
variability cannot be definitely eliminated.
 Based on the findings provided by CTA, we examined 
the possibility of a correlation between the most impor-
tant vascular risk factors and the presence of atheroscle-
rotic aortic plaques. No statistical significance was found 
for diabetes, hyperlipidemia or coronary heart disease. 
However, there was a significant correlation between ar-
terial hypertension and the presence of plaques. We also 
postulated that patients with atherosclerotic plaques in 
the aorta capable of creating emboli should probably have 
experienced more cerebrovascular events than patients 
without aortic plaques. There was indeed a clear tenden-
cy toward this assumption (1 patient with previous stroke 
and no plaques vs. 10 patients with previous strokes and 
plaques), but statistical significance was not reached (p = 
0.066), probably due to the relatively small sample size.
 In conclusion, we found CTA to be a method superior 
to TEE for detection of atherosclerotic aortic plaques, 
confirming previous studies with a smaller sample size, 
particularly in the important group of patients with cryp-
togenic stroke. In these patients, the issue of what is the 
best secondary prevention is unclear. If aortic plaques are 
not taken into consideration in the search for possible 
sources of embolism, the question arises as to whether 
these patients should receive repeated ECG monitoring 
for intermittent atrial fibrillation. Although there are no 
sufficient data at present to support evidence-based treat-
ment and secondary stroke prevention in the presence of 
aortic plaques, ongoing studies like the Aortic Arch-Re-
lated Cerebral Hazard study comparing different treat-
ment strategies will hopefully provide more information 
 [27] . Modern stroke workup should include a search for 
relevant aortic plaques, and the ASCO classification in-
cludes aortic thrombi as well as aortic plaques in the def-
inition of the atherosclerosis category  [17] . Thus, a reli-
able method for detecting aortic plaques should probably 
be part of the workup of ischemic stroke patients when no 
clear cause is found during the course of the remaining 
examinations. Our data suggest that CTA, to a greater 
degree than TEE, is the proper method for this purpose. 
This, in combination with the fact that it is a comfortable, 
quick and safe examination, renders CTA a suitable scan-
ning tool for aortic plaques in patients with cryptogenic 
ischemic stroke. For these reasons, we believe that the 
modest radiation burden of the examination can be justi-
fied, provided that patients are carefully selected. The 
aortic arch and the descending aorta should be of par-
ticular interest, as they seem to bear most of the emboli-
genic potential (i.e. possess more plaques) in this patient 
group.
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